Comparision of surfactant and surfactant with budesonide to reduce the incidence of chronic lung disease in a very preterm newborns - a randomised control trial
Phase 2
- Registration Number
- CTRI/2024/04/065406
- Lead Sponsor
- Shaik Mohammed Munthakheem
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All inborn babies less than 30 weeks, weigth less than 1500 grams, age less than 48 hours, requiring invasive or non invasive respiratory support, clinical decision to give surfactant and consent obtained
Exclusion Criteria
Infants with major congenital anomalies, birth asphyxia (Apgar score less than 4 at 5 minutes after birth), who had prolonged resuscitation, and lethal cardiopulmonary disorder were excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death or BPD or BPD and DeathTimepoint: Death or discharge
- Secondary Outcome Measures
Name Time Method EC,IVH,ROP,Sepsis,PDA, Use of post natal steriodsTimepoint: Death or discharge